Skip to main content
RecallFDAfda-F-1369-2019UNDECLARED ALLERGEN

Item FG 10191, Barlean s Ideal CBD Hemp Oil Softgel, 900 mg CBD, Less than 0.3% THC, 60 Softgels per bottle. UPC 7 05875 80112 6. Item...

Category
Units Affected
589
Recall Date
May 6, 2019
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1369-2019.

Barlean's dietary supplement product is recalled due to undeclared Sulfites. Sulfite levels of finished goods does not exceed 10 ppm.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1369-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Barlean's Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1369-2019.

Barlean's Llc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Barlean's Llc Recall FAQ

Barlean's Llc is the subject of a food safety report: Item FG 10191, Barlean s Ideal CBD Hemp Oil Softgel, 900 mg CBD, Less than 0.3% THC, 60 Softgels per bottle. UPC 7 05875 80112 6. Item.... The notice was published on May 6, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 589 units are potentially affected.